10X GENOMICS GEM-X 5’GENE EXPRESSION REAGENTS
SAM.GOV Due: May 22, 2025 at 02:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity involves the procurement of 10X Genomics GEM-X 5’ Gene Expression Reagents, specifically designed for use in clinical trials related to HIV research. The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to acquire these reagents to analyze the transcriptional activities of lymphocyte subsets in patients enrolled in ongoing clinical trials. This acquisition is critical for advancing research aimed at understanding and potentially curing HIV, thus it is essential for contractors with expertise in biological product manufacturing and those who can provide the specified brand name reagents to respond to this solicitation. The work will be performed at the NIH facility in Bethesda, Maryland, and the government intends to award a firm fixed price purchase order based on technical capability and pricing.
Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commerci

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325414
Set Aside
None
Place of Performance
Bethesda , Maryland 20892
Point of Contact
Full Name Email Phone Type
RITA DAVIS [email protected] 3017617461 primary
Tonia Alexander [email protected] 2406695124 secondary
Attachments
  • RFQ-NIAID-25-2261224_Terms_and_Conditions_FAR_52.212-5.pdf